Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

A

Ain Shams University

Status and phase

Completed
Phase 3

Conditions

Placenta Previa

Treatments

Drug: Tranexamic acid

Study type

Interventional

Funder types

Other

Identifiers

NCT03060889
AAbdelaziz

Details and patient eligibility

About

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

Full description

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa to detect efficacy of Tranexamic acid in decreasing blood loss

Enrollment

86 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Term pregnancy (more than 37 weeks of gestation)
  • Diagnosis of placenta previa was confirmed by ultrasound
  • The patient hemoglobin percentage is more than 10 mg/dl

Exclusion criteria

  • Invading placenta previa diagnosis was confirmed by Doppler ultrasound studies
  • Emergency lower segment cesarean section
  • Associated medical comorbidities

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

86 participants in 2 patient groups

Cases
Active Comparator group
Description:
Tranexamic acid 10 mg/ kg body weight will be given by intravenous infusion with induction of anesthesia in elective cesarean section for non complicated cases of placenta previa
Treatment:
Drug: Tranexamic acid
Controls
No Intervention group
Description:
Control group will not receive Tranexamic acid

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems